The University of Kentucky College of Medicine is a medical school based in Lexington, KY at the University of Kentucky's Chandler Medical Center.

During the past decade, University of Kentucky College of Medicine conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kentucky College of Medicine" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Amgen" with 1 trials sponsored, "BioMarin Pharmaceutical" with 1 trials sponsored, "Diamyd Therapeutics AB" with 1 trials sponsored and "Janssen Vaccines & Prevention B.V." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky College of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Kentucky College of Medicine" are "Chronic Migraine" (1 trials), "Episodic Migraine" (1 trials), "Head and Neck Cancer" (1 trials), "Hypoparathyroidism" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "University of Kentucky College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Kentucky College of Medicine" are "Drug" (9 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Galcanezumab" (2 trials), "100mcg rhPTH(1-84)" (1 trials), "25mcg rhPTH(1-84)" (1 trials) and "50mcg rhPTH(1-84)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Kentucky College of Medicine" are 10 trials for "All" genders.

Currently, there are NaN active trials in "University of Kentucky College of Medicine". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Kentucky College of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kentucky College of Medicine, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".